Valiant Laboratories Ltd

NSE: VALIANTLAB · BSE: 543998 · Pharmaceuticals & Biotechnology · 7 announcements

Share price: ₹124.87
Market cap: ₹678.2 Cr
Revenue (annual): ₹237.5 Cr
Net profit (annual): ₹-3.27 Cr
P/E (TTM): 42.4×Sector 50.4×
Promoter holding: 74.94%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Other Announcement 1 Credit Rating 1 Annual Report 1 Annual General Meeting 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

3 Sep 2026 17:22 IST NSE

Annual General Meeting

Valiant Laboratories Annual General Meeting

Valiant Laboratories Limited issued a notice for its Annual General Meeting scheduled for September 28, 2026, covering financial adoption, director appointments, and related party transaction approvals.

Read the filing ↗